Drug Type Small molecule drug |
Synonyms SDN 207, SDN207, SND207 |
Target |
Mechanism PKN1 inhibitors(protein kinase N1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | CH | 22 Mar 2024 | |
Leukemia | Preclinical | CH | 22 Mar 2024 | |
Lymphoma | Preclinical | CH | 22 Mar 2024 | |
Lymphoma | Preclinical | CH | 22 Mar 2024 | |
Solid tumor | Preclinical | CH | 22 Mar 2024 | |
Solid tumor | Preclinical | CH | 22 Mar 2024 |